Impact on Survival of Warfarin in Patients with Pulmonary Arterial Hypertension Receiving Subcutaneous Treprostinil

ConclusionsLong‐term anticoagulation with warfarin was not associated with any significant effect on survival in PAH or idiopathic PAH patients treated with SQ treprostinil.This article is protected by copyright. All rights reserved.

Source: Cardiovascular Therapeutics - June 23, 2017 Category: Cardiology Authors: Mona Ascha, Xuan Zhou, Youlan Rao, Omar A. Minai, Adriano R. Tonelli Tags: Original Research Article Source Type: research